This inventor holds 1 USPTO granted patent. Top assignee: National Yang Ming Chiao Tung University. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: C Allen Chang: Innovator in Targeted Prodrug Enzyme Technology
Introduction
C Allen Chang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of targeted therapies, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy of cancer treatments through advanced biotechnological methods.
Latest Patents
C Allen Chang holds a patent for a "Targeted prodrug cytosine deaminase fusion carrier and application thereof." This invention provides a targeted prodrug enzyme fusion carrier that includes a targeted molecule and a prodrug enzyme. The carrier is designed to effectively identify and bind to tumor cells and tumor-induced angiogenesis. Additionally, it features a theranostic system that utilizes in vivo nuclear medicine for the clinical diagnosis and treatment of individual patients with tumors. He has 1 patent to his name.
Career Highlights
C Allen Chang is affiliated with National Yang Ming Chiao Tung University, where he continues to advance research in targeted drug delivery systems. His academic and research endeavors have positioned him as a key figure in the field of biotechnology.
Collaborations
Some of his notable coworkers include Hsin-Ell Wang and Jia-Je Li, who have collaborated with him on various research projects.
Conclusion
C Allen Chang's innovative work in targeted prodrug enzyme technology represents a significant advancement in cancer treatment methodologies. His contributions continue to influence the field and offer hope for improved therapeutic strategies.